Healthcare -
Biotechnology - NASDAQ - US
$ 43.33
-0.161 %
$ 4 B
Market Cap
-6.82
P/E
RARE - OPERATING INCOME
Operating Income RARE - Ultragenyx Pharmaceutical Inc.
-569 M
LAST VALUE
-22.11%
2 YEAR CAGR
-8.92%
5 YEAR CAGR
-33.24%
10 YEAR CAGR